BR112021022916A2 - Bactérias produtoras de ácido lático frutofílico - Google Patents
Bactérias produtoras de ácido lático frutofílicoInfo
- Publication number
- BR112021022916A2 BR112021022916A2 BR112021022916A BR112021022916A BR112021022916A2 BR 112021022916 A2 BR112021022916 A2 BR 112021022916A2 BR 112021022916 A BR112021022916 A BR 112021022916A BR 112021022916 A BR112021022916 A BR 112021022916A BR 112021022916 A2 BR112021022916 A2 BR 112021022916A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid producing
- fructophilic
- producing bacteria
- lactic acid
- lactic
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 4
- 235000014655 lactic acid Nutrition 0.000 title abstract 2
- 239000004310 lactic acid Substances 0.000 title abstract 2
- 229930091371 Fructose Natural products 0.000 abstract 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 2
- 239000005715 Fructose Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 241000193749 Bacillus coagulans Species 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/52—Propionic acid; Butyric acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/54—Acetic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2019/031965 WO2020231397A1 (en) | 2019-05-13 | 2019-05-13 | Fructophilic lactic acid producing bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021022916A2 true BR112021022916A2 (pt) | 2022-01-18 |
Family
ID=73289609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021022916A BR112021022916A2 (pt) | 2019-05-13 | 2019-05-13 | Bactérias produtoras de ácido lático frutofílico |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3969606A4 (es) |
| JP (1) | JP7469332B2 (es) |
| KR (1) | KR20220007660A (es) |
| CN (1) | CN114207107A (es) |
| AU (1) | AU2019445706B2 (es) |
| BR (1) | BR112021022916A2 (es) |
| CA (1) | CA3140038A1 (es) |
| MX (1) | MX2021013902A (es) |
| WO (1) | WO2020231397A1 (es) |
| ZA (1) | ZA202110214B (es) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767203B2 (en) * | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| JP4888622B2 (ja) | 2001-06-04 | 2012-02-29 | キユーピー株式会社 | オリゴヌクレオチド及びこれをプライマーとして用いたバチルスコアグランスの検出方法 |
| US20090081300A1 (en) * | 2005-11-16 | 2009-03-26 | Pro Natura Gesellschaft Fuer Gesunde Ernaehrung Mb | Agent for use in the case of fructose intolerance |
| CN100473720C (zh) * | 2007-10-18 | 2009-04-01 | 中国科学院微生物研究所 | 一种生产l-乳酸的方法及其专用凝结芽孢杆菌 |
| JP2010148402A (ja) | 2008-12-24 | 2010-07-08 | Toyo Shokuhin Kenkyusho | バチルス・コアギュランスを検出する方法および検出用オリゴヌクレオチド |
| CN101914465B (zh) * | 2010-05-20 | 2012-10-03 | 上海交通大学 | 用于制备l-乳酸的凝结芽孢杆菌及其应用方法 |
| JP5989661B2 (ja) * | 2010-12-17 | 2016-09-07 | コンパニ・ジェルベ・ダノンＣｏｍｐａｇｎｉｅ Ｇｅｒｖａｉｓ Ｄａｎｏｎｅ | 消化器の病的状態の改善に使用するためのラクトコッカスラクティス株 |
| US9371548B2 (en) * | 2011-04-14 | 2016-06-21 | Industrial Technology Research Institute | Method for producing butyric acid, butanol and butyrate ester |
| JP5892580B2 (ja) | 2011-04-14 | 2016-03-23 | 国立大学法人 琉球大学 | 新規乳酸菌及びｌ−乳酸の製造方法及び乳酸菌を含む食品および薬品 |
| US9596861B2 (en) | 2013-12-24 | 2017-03-21 | Sami Labs Limited | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
| JP6486612B2 (ja) | 2014-05-27 | 2019-03-20 | 株式会社山田養蜂場本社 | 抗アレルギー作用を有する乳酸菌及びその用途 |
| KR102089566B1 (ko) * | 2014-08-29 | 2020-03-16 | 무하메드 마제에드 | 유산균의 생균수를 증진시키기 위한 방법 및 이의 유용한 조성물 |
| EP3240553B1 (en) * | 2016-01-07 | 2020-01-01 | Sami Labs Limited | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using bacillus |
-
2019
- 2019-05-13 JP JP2021568485A patent/JP7469332B2/ja active Active
- 2019-05-13 CA CA3140038A patent/CA3140038A1/en active Pending
- 2019-05-13 MX MX2021013902A patent/MX2021013902A/es unknown
- 2019-05-13 WO PCT/US2019/031965 patent/WO2020231397A1/en unknown
- 2019-05-13 CN CN201980097794.9A patent/CN114207107A/zh active Pending
- 2019-05-13 BR BR112021022916A patent/BR112021022916A2/pt unknown
- 2019-05-13 EP EP19929028.9A patent/EP3969606A4/en active Pending
- 2019-05-13 KR KR1020217040516A patent/KR20220007660A/ko unknown
- 2019-05-13 AU AU2019445706A patent/AU2019445706B2/en active Active
-
2021
- 2021-12-09 ZA ZA2021/10214A patent/ZA202110214B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3969606A1 (en) | 2022-03-23 |
| JP2022536252A (ja) | 2022-08-15 |
| JP7469332B2 (ja) | 2024-04-16 |
| AU2019445706A1 (en) | 2022-01-06 |
| CN114207107A (zh) | 2022-03-18 |
| CA3140038A1 (en) | 2020-11-19 |
| MX2021013902A (es) | 2022-03-11 |
| AU2019445706B2 (en) | 2024-04-18 |
| ZA202110214B (en) | 2023-06-28 |
| KR20220007660A (ko) | 2022-01-18 |
| WO2020231397A1 (en) | 2020-11-19 |
| EP3969606A4 (en) | 2023-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Acne, the skin microbiome, and antibiotic treatment | |
| ES2524432T3 (es) | Bacterias del ácido láctico como cepas probióticas y composiciones que contienen las mismas | |
| AR106800A1 (es) | Composiciones que comprenden cepas bacterianas | |
| NO974371L (no) | Epitelialadhesive lactobacilli | |
| BRPI0516437A (pt) | utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral | |
| WO2019066599A3 (ko) | 신규 유산균 및 이의 용도 | |
| RU2018106510A (ru) | Композиция молочнокислых бактерий для применения в лечении инфекций, обусловленных Propionibacterium acnes, и, в частности, акне | |
| UA109112C2 (uk) | Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями | |
| BRPI0516489A (pt) | produtos da bactéria do ácido lático e da bìfida-bactéria com um alto grau de dispersibilidade | |
| Nicoletti et al. | Non‑pathogenic microflora of a spring water with regenerative properties | |
| WO2022272248A9 (en) | Cbl-b modulators and uses thereof | |
| BRPI0609093A8 (pt) | Processo para preparar uma cepa de bifidobacterium sp. que contém um gene tetw mutante em seu cromossomo, cepa de bifidobacterium e uso da mesma | |
| WO2019098810A3 (ko) | 신규 유산균 및 이의 용도 | |
| BR112021015751A2 (pt) | Vetores de terapia genética para tratamento da doença de danon | |
| BR112022019932A2 (pt) | Composições para saúde metabólica | |
| Lahiri et al. | Bacillus clausii as an adjuvant therapy in acute childhood diarrhoea | |
| Uçkay et al. | Posttraumatic ankle arthritis due to a novel Nocardia species | |
| Wang | The entropy perspective on human illness and aging | |
| BR112021022916A2 (pt) | Bactérias produtoras de ácido lático frutofílico | |
| Pang et al. | Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link | |
| BR112022008559A2 (pt) | Bactéria produtora de serotonina | |
| MX2020013857A (es) | Bacterias bifidobacterium bifidum no viables y usos de las mismas. | |
| Dinić et al. | Nasal carriage of Staphylococcus aureus in healthy adults and in school children | |
| Riffat | Prevalence, Antibiotic Susceptibility Pat-tern and Demographic Factors Related to Methicillin Resistant Staphy-lococcus aureus in Lahore, Pakistan | |
| BR112016024970A2 (pt) | microorganismos para produzir diamina e processo para produzir diamina usando os mesmos |